生物活性 | |||
---|---|---|---|
描述 | Polmacoxib (CG100649) is a pioneering orally active nonsteroidal anti-inflammatory drug (NSAID) with the unique capability of dual inhibition, targeting COX-2 with an IC50 approximately 0.1 μg/ml and carbonic anhydrase[1]. This first-in-class agent shows promise in inhibiting the growth of colorectal adenomas and tumors in mouse models[2]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
2.77mL 0.55mL 0.28mL |
13.84mL 2.77mL 1.38mL |
27.67mL 5.53mL 2.77mL |
参考文献 |
---|